• Understanding the development of synthetic cannabinoids through advanced AI platforms and in silico modelling to design novel synthetic compounds
• Illustrating how these compounds bind to CB1 and CB2 receptors and how their activity can be biased
• A case study to explore the connection between the endocannabinoid system and endometriosis, emphasizing cannabinoid intervention as a promising yet under-researched therapeutic approach

NEW DATA